XML 63 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Insurance Liabilities
12 Months Ended
Dec. 31, 2019
Insurance Liabilities  
Insurance Liabilities

8. Insurance Liabilities

Contractholder Funds

Major components of contractholder funds in the consolidated statements of financial position were as follows:

December 31, 

 

    

2019

    

2018

  

(in millions)

 

Liabilities for investment contracts:

Liabilities for individual annuities

$

13,457.5

$

12,913.9

GICs

10,423.5

 

10,321.7

Funding agreements

8,640.6

 

7,729.5

Other investment contracts

1,596.7

 

1,652.2

Total liabilities for investment contracts

34,118.3

 

32,617.3

Universal life and other reserves

7,249.2

 

7,082.4

Total contractholder funds

$

41,367.5

$

39,699.7

8.  Insurance Liabilities – (continued)

Our GICs and funding agreements contain provisions limiting or prohibiting early surrenders, which typically include penalties for early surrenders, minimum notice requirements or, in the case of funding agreements with survivor options, minimum pre-death holding periods and specific maximum amounts.

Funding agreements include those issued directly to nonqualified institutional investors and those issued to the FHLB Des Moines under their membership funding programs. As of December 31, 2019 and 2018, $4,010.9 million and $3,512.2 million, respectively, of liabilities were outstanding with respect to issuances under the program with FHLB Des Moines. In addition, we have five separate  programs where the funding agreements have been issued directly or indirectly to unconsolidated special purpose entities. Claims for principal and interest under funding agreements are afforded equal priority to claims of life insurance and annuity policyholders under insolvency provisions of Iowa Insurance Laws.

Principal Life was authorized to issue up to $4.0 billion of funding agreements under a program established in 1998 to support the prospective issuance of medium term notes by an unaffiliated entity in non-U.S. markets. As of December 31, 2019 and 2018, $75.2 million and $109.6 million, respectively, of liabilities were outstanding with respect to the issuance outstanding under this program. Principal Life was also authorized to issue up to Euro 4.0 billion (approximately USD$5.3 billion) of funding agreements under a program established in 2006 to support the prospective issuance of medium term notes by an unaffiliated entity in non-U.S. markets. The unaffiliated entity is an unconsolidated special purpose entity. As of December 31, 2019 and 2018, $112.2 million and $114.4 million, respectively, of liabilities were outstanding with respect to issuances outstanding under this program. Principal Life does not anticipate any new issuance activity under either of these programs due to the existence of the program established in 2011 described below.

In addition, Principal Life was authorized to issue up to $7.0 billion of funding agreements under a program established in 2001 to support the prospective issuance of medium term notes by an unaffiliated entity in both domestic and international markets. The unaffiliated entity is an unconsolidated special purpose entity. As of December 31, 2019 and 2018, $201.7 million and $201.6 million, respectively, of liabilities were being held with respect to issuances outstanding under this program. Principal Life does not anticipate any new issuance activity under this program, given our December 2005 termination of the dealership agreement for this program and the availability of the program established in 2011 described below.

Additionally, Principal Life was authorized to issue up to $9.0 billion of funding agreements under a program that was originally established in March 2004 to support the prospective issuance of medium term notes by unaffiliated entities in both domestic and international markets. Under this program, both the notes and the supporting funding agreements were registered with the United States Securities and Exchange Commission (“SEC”). As of both December 31, 2019 and 2018, $26.2 million of liabilities were being held with respect to issuances outstanding under this program. In contrast with direct funding agreements, GIC issuances and the other three funding agreement-backed medium term note programs described above, Principal Life's payment obligations on each funding agreement issued under this SEC-registered program are guaranteed by PFG. Principal Life does not anticipate any new issuance activity under this program due to the existence of the program established in 2011 described below.

Principal Life was authorized to issue up to $5.0 billion of funding agreements under a program that was originally established in 2011 to support the prospective issuance of medium term notes by an unaffiliated entity in both domestic and international markets. The unaffiliated entity is an unconsolidated special purpose entity. In June 2015, this program was amended to authorize issuance of up to an additional $4.0 billion in recognition of the use of nearly all $5.0 billion of existing issuance authorization. In November 2017, this program was amended to authorize issuance of up to an additional $4.0 billion. As of December 31, 2019 and 2018, $4,214.3 million and $3,765.3 million, respectively, of liabilities were being held with respect to issuances outstanding under this program. Similar to the SEC-registered program, Principal Life’s payment obligations on each funding agreement issued under this program are guaranteed by PFG. The program established in 2011 is not registered with the SEC.

8. Insurance Liabilities – (continued)

Liability for Unpaid Claims

The liability for unpaid claims is reported in future policy benefits and claims within our consolidated statements of financial position. Activity associated with unpaid claims was as follows:

For the year ended December 31, 

 

    

2019

    

2018

    

2017

  

(in millions)

 

Balance at beginning of year

$

2,252.7

$

2,130.5

$

2,001.3

Less: reinsurance recoverable

404.3

375.8

340.3

Net balance at beginning of year

1,848.4

1,754.7

1,661.0

Incurred:

Current year

1,361.3

 

1,268.8

 

1,196.6

Prior years

0.8

 

0.3

 

18.2

Total incurred

1,362.1

 

1,269.1

 

1,214.8

Payments:

Current year

869.4

 

815.7

 

767.2

Prior years

379.4

 

359.7

 

353.9

Total payments

1,248.8

 

1,175.4

 

1,121.1

Net balance at end of year

1,961.7

1,848.4

1,754.7

Plus: reinsurance recoverable

403.8

404.3

375.8

Balance at end of year

$

2,365.5

$

2,252.7

$

2,130.5

Amounts not included in the rollforward above:

Claim adjustment expense liabilities

$

57.9

$

54.6

$

50.7

Incurred liability adjustments relating to prior years, which affected current operations during 2019, 2018 and 2017, resulted in part from developed claims for prior years being different than were anticipated when the liabilities for unpaid claims were originally estimated. These trends have been considered in establishing the current year liability for unpaid claims.

Short-Duration Contracts

Claims Development

The following tables present undiscounted information about claims development by incurral year, including separate information about incurred claims and paid claims net of reinsurance for the periods indicated. The tables also include information on incurred but not reported claims and the cumulative number of reported claims.

The tables present information for the number of years for which claims incurred typically remain outstanding, but do not exceed ten years. The data is disaggregated into groupings of claims with similar characteristics, such as duration of the claim payment period and average claim amount, and with consideration to the overall size of the groupings. Outstanding liabilities equal total net incurred claims less total net paid claims plus outstanding liabilities for net unpaid claims of prior years.

8.  Insurance Liabilities – (continued)

LTD and Group Life Waiver Claims

Incurred

Cumulative

but not

number of

reported

reported

Net incurred claims (1)

claims

claims

December 31, 

   

2010

   

2011

   

2012

   

2013

   

2014

   

2015

   

2016

   

2017

   

2018

   

2019

   

2019

  

  

2019

($ in millions)

Incurral year

2010

$

184.1

$

176.7

$

176.2

$

172.0

$

162.7

$

155.7

$

154.1

$

153.4

$

152.1

$

151.8

$

0.1

5,649

2011

203.7

192.6

185.4

184.8

178.4

172.3

169.6

167.6

166.5

0.1

6,290

2012

217.9

200.0

191.1

189.5

181.8

174.8

173.3

171.9

0.1

6,444

2013

219.3

203.3

188.4

190.7

182.3

179.5

177.1

0.1

7,050

2014

242.2

231.4

214.4

218.1

206.2

201.9

0.1

7,596

2015

231.0

227.2

217.2

215.3

208.2

0.1

7,174

2016

229.8

228.4

219.4

219.5

5.4

6,161

2017

238.4

239.7

243.1

8.0

6,053

2018

239.4

245.1

3.8

5,668

2019

255.2

104.6

3,472

Total net incurred claims

$

2,040.3

    Net cumulative paid claims (1)

        

          

December 31, 

  

  

   

2010

   

2011

   

2012

   

2013

   

2014

   

2015

   

2016

   

2017

   

2018

   

2019

   

(in millions)

Incurral year

2010

$

10.4

$

46.5

$

67.1

$

78.4

$

85.9

$

94.2

$

100.9

$

107.2

$

112.1

$

116.7

                 

                  

2011

11.2

50.0

72.5

85.7

95.4

105.2

112.6

119.3

125.4

2012

13.8

55.1

80.8

93.7

104.6

112.9

120.0

126.1

2013

12.5

55.0

81.4

97.0

106.4

116.4

123.2

2014

16.1

66.0

96.3

111.8

122.3

132.4

2015

16.9

67.0

98.0

114.6

126.8

2016

16.2

70.6

105.6

124.9

2017

17.8

76.5

115.0

2018

20.1

79.9

2019

19.2

Total net paid claims

1,089.6

All outstanding liabilities for unpaid claims prior to 2010 net of reinsurance

237.8

Total outstanding liabilities for unpaid claims net of reinsurance

$

1,188.5

(1)2010-2018 unaudited.

8. Insurance Liabilities – (continued)

Dental, Vision, STD, Critical Illness and Accident Claims

Incurred

Cumulative

but not

number of

reported

reported

Net incurred claims (1)

claims

claims

December 31, 

    

2018

    

2019

    

2019

    

2019

  

($ in millions)

Incurral year

2018

$

648.3

$

640.0

$

3,032,617

2019

724.7

45.0

3,184,519

Total net incurred claims

$

1,364.7

Net cumulative

paid claims (1)

December 31, 

2018

    

2019

    

    

(in millions)

Incurral year

2018

$

589.1

$

640.0

2019

653.5

Total net paid claims

1,293.5

All outstanding liabilities for unpaid claims prior to 2018 net of reinsurance

Total outstanding liabilities for unpaid claims net of reinsurance

$

71.2

(1)2018 unaudited.

8. Insurance Liabilities – (continued)

Group Life Claims

Incurred

Cumulative

but not

number of

reported

reported

Net incurred claims (1)

claims

claims

December 31, 

    

2018

    

2019

    

2019

    

2019

  

($ in millions)

Incurral year

2018

$

239.6

$

238.4

$

0.7

5,220

2019

228.3

23.0

4,625

Total net incurred claims

$

466.7

Net cumulative

paid claims (1)

December 31, 

    

2018

    

2019

    

    

(in millions)

Incurral year

2018

$

193.9

$

236.5

2019

181.7

Total net paid claims

418.2

All outstanding liabilities for unpaid claims prior to 2018 net of reinsurance

1.0

Total outstanding liabilities for unpaid claims net of reinsurance

$

49.5

(1)2018 unaudited.

Reconciliation of Unpaid Claims to Liability for Unpaid Claims

Our reconciliation of net outstanding liabilities for unpaid claims of short-duration contracts to the liability for unpaid claims follows:

December 31, 2019

Dental, Vision, STD,

LTD and Group Life

Critical Illness and

    

Waiver

    

Accident

    

Group Life

    

Consolidated

  

(in millions)

Net outstanding liabilities for unpaid claims

$

1,188.5

$

71.2

$

49.5

$

1,309.2

Reconciling items:

Reinsurance recoverable on unpaid claims

56.4

0.9

57.3

Impact of discounting

(215.0)

(215.0)

Liability for unpaid claims - short-duration contracts

$

1,029.9

$

71.2

$

50.4

1,151.5

Insurance contracts other than short-duration

1,214.0

Liability for unpaid claims

$

2,365.5

8. Insurance Liabilities – (continued)

Claim Duration and Payout

Our historical average percentage of claims paid in each year from incurral was as follows:

December 31, 2019 (1)

Dental, Vision, STD,

LTD and Group Life

Critical Illness and

Group

Year

    

Waiver

    

Accident

    

Life

1

7.6

%  

91.7

%  

81.7

%

2

24.2

8.0

17.0

3

14.9

4

8.1

5

5.6

6

5.3

7

4.2

8

3.9

9

3.5

10

3.1

(1)Unaudited.

Discounting

The following table provides the carrying amount of liabilities reported at present value for short-duration contract unpaid claims. We use a range of discount rates to derive the present value of the unpaid claims. The ranges of discount rates as well as the aggregate amount of discount deducted to derive the liabilities for unpaid claims and interest accretion recognized are also disclosed. Interest accretion is included in benefits, claims and settlement expenses within our consolidated statements of operations.

  

Dental, Vision, STD,

  

LTD and Group Life

Critical Illness and

 

    

Waiver

 

Accident

Group Life

($ in millions)

Carrying amount of liabilities for unpaid claims

    

    

    

December 31, 2019

$

1,029.9

$

71.2

$

50.4

December 31, 2018

1,020.0

59.3

49.7

Range of discount rates

December 31, 2019

3.3

-

7.0

%

-

%

-

%

December 31, 2018

3.3

-

7.0

-

-

Aggregate amount of discount

December 31, 2019

$

215.0

$

$

December 31, 2018

217.7

Interest accretion

For the year ended:

December 31, 2019

$

34.2

$

$

December 31, 2018

34.5

December 31, 2017

35.0